Litcius/Paper detail

Real-World Evidence of the Incidence of and Risk Factors for Type 1 Diabetes Mellitus and Hypothyroidism as Immune-Related Adverse Events Associated With Programmed Cell Death-1 Inhibitors

Koki Shimada, Hiroyuki Yamamoto, Eiji Nakatani, Hiraku Kumamaru, Shiori Nishimura, Nao Ichihara, Norimichi Hirahara, Kiyoshi Mori, Masato Kotani, Yoshiki Miyachi, Hiroaki Miyata

2020Endocrine Practice21 citationsDOI

Topics & Concepts

MedicineIncidence (geometry)Hazard ratioInternal medicineType 1 diabetesAdverse effectDiabetes mellitusCumulative incidenceCohortPediatricsEndocrinologyOpticsPhysicsConfidence intervalCancer Immunotherapy and BiomarkersCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts
Real-World Evidence of the Incidence of and Risk Factors for Type 1 Diabetes Mellitus and Hypothyroidism as Immune-Related Adverse Events Associated With Programmed Cell Death-1 Inhibitors | Litcius